RecallDepth
Class III Ongoing

Eptifibatide Injection, 75 mg/100 mL vial for weight-adjusted bolus dosing, 1x100 mL Single-dose Vial, For Intravenous Use Only, Rx Only, Manufactured by: Hainan Poly Pharm. Co., Ltd., Guilinyang Economic Development Area, Haikou, Hainan Province, China 571127; Distributed by: Slate Run Pharmaceuticals, LLC, Columbus, Ohio 43215. NDC Slate Run Carton Label: 70436-027-80; NDC ProRx Carton Label: 70436-163-80

Company
Slate Run Pharmaceuticals
Recall Initiated
February 12, 2026
Posted
March 4, 2026
Recall Number
D-0343-2026
Voluntary / Mandated
Voluntary: Firm initiated
Firm Location
Columbus, OH, United States

Reason for Recall

Labeling: Not Elsewhere Classified. The carton for Eptifibatide Injection 75 mg/100 mL states 75 mg/100 mL vial for weight-adjusted bolus dosing. The approved statement is 75 mg/100 mL vial for weight-adjusted infusion.

Distribution

Nationwide within the USA.

Lot / Code Info

All lots within expiry

More recalls by Slate Run Pharmaceuticals

View all recalls by this company →

Other recent Class III Drug recalls